| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.4M | -20.3% |
| Cost of Revenue | $1.3M | -12.0% |
| Gross Profit | $1.2M | -27.9% |
| R&D Expense | $53.8M | -9.9% |
| SG&A Expense | $44.8M | -11.4% |
| Operating Income | -$116.1M | -6.9% |
| Pre-tax Income | -$101.3M | -0.3% |
| Income Tax | $58K | +3.6% |
| Net Income | -$101.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.6M | -56.1% |
| Accounts Receivable | $561K | -57.9% |
| Inventory | $3.2M | -21.4% |
| Current Assets | $175.9M | -19.3% |
| Total Assets | $245.6M | -0.9% |
| Current Liabilities | $23.0M | +26.6% |
| Total Liabilities | $25.4M | -21.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.7M | -7.9% |
| Capital Expenditures | $2.5M | -45.1% |
| Investing Cash Flow | -$28.3M | +13.3% |
| Financing Cash Flow | $95.4M | +166.0% |
| Free Cash Flow | -$97.2M | -5.3% |
| -0.3% |
| EPS (Basic) | -$0.51 | +28.2% |
| EPS (Diluted) | -$0.51 | +28.2% |
| Stockholders' Equity |
| $220.2M |
| +2.2% |